Cover
Cover - shares | 3 Months Ended | |
Mar. 31, 2022 | Apr. 29, 2022 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2022 | |
Document Transition Report | false | |
Entity File Number | 001-39497 | |
Entity Registrant Name | UNITY SOFTWARE INC. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 27-0334803 | |
Entity Address, Address Line One | 30 3rd Street | |
Entity Address, City or Town | San Francisco | |
Entity Address, State or Province | CA | |
Entity Address, Postal Zip Code | 94103‑3104 | |
City Area Code | 415 | |
Local Phone Number | 539‑3162 | |
Title of 12(b) Security | Common stock, $0.000005 par value | |
Trading Symbol | U | |
Security Exchange Name | NYSE | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 296,013,003 | |
Amendment Flag | false | |
Document Fiscal Year Focus | 2022 | |
Document Fiscal Period Focus | Q1 | |
Entity Central Index Key | 0001810806 | |
Current Fiscal Year End Date | --12-31 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Current assets: | ||
Cash and cash equivalents | $ 1,152,014 | $ 1,055,776 |
Marketable securities | 656,581 | 681,323 |
Accounts receivable, net of allowances of $6,259 and $5,447 as of March 31, 2022 and December 31, 2021, respectively | 332,958 | 340,491 |
Prepaid expenses | 48,734 | 39,097 |
Other current assets | 33,910 | 34,423 |
Total current assets | 2,224,197 | 2,151,110 |
Property and equipment, net | 110,170 | 106,106 |
Operating lease right‑of‑use assets | 101,486 | 98,393 |
Goodwill | 1,657,817 | 1,620,127 |
Intangible assets, net | 789,144 | 814,386 |
Restricted cash | 10,678 | 10,823 |
Other assets | 53,168 | 40,401 |
Total assets | 4,946,660 | 4,841,346 |
Current liabilities: | ||
Accounts payable | 13,005 | 14,009 |
Accrued expenses and other current liabilities | 121,976 | 144,873 |
Publisher payables | 213,857 | 237,637 |
Income and other taxes payable | 54,740 | 64,759 |
Deferred revenue | 200,218 | 140,528 |
Operating lease liabilities | 26,464 | 23,729 |
Total current liabilities | 630,260 | 625,535 |
Convertible notes | 1,704,145 | 1,703,035 |
Long-term deferred revenue | 145,676 | 15,945 |
Long-term operating lease liabilities | 94,340 | 92,539 |
Other long-term liabilities | 10,097 | 9,901 |
Total liabilities | 2,584,518 | 2,446,955 |
Commitments and contingencies (Note 11) | ||
Stockholders’ equity: | ||
Common stock, $0.000005 par value; 1,000,000 and 1,000,000 shares authorized as of March 31, 2022 and December 31, 2021, respectively; 295,847 and 292,592 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively | 2 | 2 |
Additional paid-in capital | 3,879,589 | 3,729,874 |
Accumulated other comprehensive loss | (8,267) | (3,858) |
Accumulated deficit | (1,509,182) | (1,331,627) |
Total stockholders’ equity | 2,362,142 | 2,394,391 |
Total liabilities and stockholders’ equity | $ 4,946,660 | $ 4,841,346 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Statement of Financial Position [Abstract] | ||
Accounts receivable, allowances | $ 6,259 | $ 5,447 |
Common stock, par value (USD per share) | $ 0.000005 | $ 0.000005 |
Common stock, authorized (in shares) | 1,000,000,000 | 1,000,000,000 |
Common stock, issued (in shares) | 295,847,000 | 292,592,000 |
Common stock, outstanding (in shares) | 295,847,000 | 292,592,000 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Income Statement [Abstract] | ||
Revenue | $ 320,126 | $ 234,772 |
Cost of revenue | 93,833 | 58,734 |
Gross profit | 226,293 | 176,038 |
Operating expenses | ||
Research and development | 221,040 | 154,015 |
Sales and marketing | 103,939 | 69,793 |
General and administrative | 72,475 | 63,132 |
Total operating expenses | 397,454 | 286,940 |
Loss from operations | (171,161) | (110,902) |
Interest expense | (1,111) | (115) |
Interest income and other expense, net | 941 | 1,565 |
Loss before provision for income taxes | (171,331) | (109,452) |
Provision for (benefit from) income taxes | 6,224 | (1,992) |
Net loss | $ (177,555) | $ (107,460) |
Basic and diluted net loss per share: | ||
Net loss per share attributable to our common stockholders, basic (USD per share) | $ (0.60) | $ (0.39) |
Net loss per share attributable to our common stockholders, diluted (USD per share) | $ (0.60) | $ (0.39) |
Weighted-average shares used in per share calculation attributable to our common stockholders, basic (in shares) | 294,341 | 276,068 |
Weighted-average shares used in per share calculation attributable to our common stockholders, diluted (in shares) | 294,341 | 276,068 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Statement of Comprehensive Income [Abstract] | ||
Net loss | $ (177,555) | $ (107,460) |
Other comprehensive loss, net of taxes: | ||
Change in foreign currency translation adjustment | 19 | (31) |
Change in unrealized losses on marketable securities | (4,428) | (103) |
Other comprehensive loss | (4,409) | (134) |
Comprehensive loss | $ (181,964) | $ (107,594) |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands | Total | Adjustment | Common Stock | Additional Paid-In Capital | Accumulated Other Comprehensive Loss | Accumulated Deficit | Accumulated DeficitAdjustment |
Beginning balance (in shares) at Dec. 31, 2020 | 273,537,218 | ||||||
Beginning balance at Dec. 31, 2020 | $ 2,037,143 | $ (1,522) | $ 2 | $ 2,838,057 | $ (3,418) | $ (797,498) | $ (1,522) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Issuance of common stock from employee equity plans (in shares) | 4,544,498 | ||||||
Issuance of common stock from employee equity plans | 22,624 | 22,624 | |||||
Issuance of common stock for settlement of RSUs (in shares) | 1,088,445 | ||||||
Issuance of common stock for settlement of RSUs | 0 | ||||||
Stock‑based compensation expense | 64,424 | 64,424 | |||||
Stock-based compensation expense in connection with modified awards for certain employees | 2,137 | 2,137 | |||||
Net loss | (107,460) | (107,460) | |||||
Other comprehensive loss | (134) | (134) | |||||
Ending balance (in shares) at Mar. 31, 2021 | 279,170,161 | ||||||
Ending balance at Mar. 31, 2021 | 2,017,212 | $ 2 | 2,927,242 | (3,552) | (906,480) | ||
Beginning balance (in shares) at Dec. 31, 2021 | 292,592,356 | ||||||
Beginning balance at Dec. 31, 2021 | $ 2,394,391 | $ 2 | 3,729,874 | (3,858) | (1,331,627) | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Issuance of common stock from employee equity plans (in shares) | 1,952,058 | 2,160,044 | |||||
Issuance of common stock from employee equity plans | $ 30,216 | 30,216 | |||||
Issuance of common stock for settlement of RSUs (in shares) | 925,030 | ||||||
Issuance of common stock for settlement of RSUs | 0 | ||||||
Common stock issued in connection with acquisitions (in shares) | 169,321 | ||||||
Common stock issued in connection with acquisitions | 16,072 | 16,072 | |||||
Stock‑based compensation expense | 103,195 | 103,195 | |||||
Stock-based compensation expense in connection with modified awards for certain employees | 232 | 232 | |||||
Net loss | (177,555) | (177,555) | |||||
Other comprehensive loss | (4,409) | (4,409) | |||||
Ending balance (in shares) at Mar. 31, 2022 | 295,846,751 | ||||||
Ending balance at Mar. 31, 2022 | $ 2,362,142 | $ 2 | $ 3,879,589 | $ (8,267) | $ (1,509,182) |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Operating activities | ||
Net loss | $ (177,555) | $ (107,460) |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||
Depreciation and amortization | 41,472 | 11,832 |
Stock-based compensation expense | 103,195 | 64,424 |
Stock-based compensation expense in connection with modified awards for certain employees | 232 | 2,137 |
Other | 3,260 | 1,441 |
Changes in assets and liabilities, net of effects of acquisitions: | ||
Accounts receivable, net | 7,532 | (25,061) |
Prepaid expenses | (9,624) | (9,888) |
Other current assets | 508 | (2,318) |
Operating lease right-of-use ("ROU") assets | 6,337 | 5,907 |
Deferred tax, net | (629) | (1,824) |
Other assets | (2,242) | (11,569) |
Accounts payable | 38 | 6,303 |
Accrued expenses and other current liabilities | (22,439) | (13,767) |
Publisher payables | (23,780) | 4,047 |
Income and other taxes payable | (10,012) | (10,104) |
Operating lease liabilities | (4,894) | (7,492) |
Other long-term liabilities | 487 | 309 |
Deferred revenue | 189,414 | 4,201 |
Net cash provided by (used in) operating activities | 101,300 | (88,882) |
Investing activities | ||
Purchase of marketable securities | (82,777) | (129,082) |
Proceeds from principal repayments on marketable securities | 23,182 | 2,017 |
Maturities of marketable securities | 77,701 | 78,000 |
Purchase of non-marketable investments | (15,000) | (4,000) |
Purchase of property and equipment | (14,929) | (11,744) |
Business acquisitions, net of cash acquired | (23,637) | (24,817) |
Net cash used in investing activities | (35,460) | (89,626) |
Financing activities | ||
Proceeds from issuance of common stock from employee equity plans | 30,216 | 22,624 |
Net cash provided by financing activities | 30,216 | 22,624 |
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash | 37 | 9 |
Increase (decrease) in cash, cash equivalents, and restricted cash | 96,093 | (155,875) |
Cash and restricted cash, beginning of period | 1,066,599 | 1,293,947 |
Cash, cash equivalents, and restricted cash, end of period | 1,162,692 | 1,138,072 |
Supplemental disclosure of cash flow information: | ||
Cash paid for interest | 0 | 84 |
Cash paid for income taxes, net of refunds | 1,087 | (1,197) |
Supplemental disclosures of non‑cash investing and financing activities: | ||
Fair value of common stock issued as consideration for business acquisitions | 16,072 | 0 |
Accrued property and equipment | $ 6,416 | $ 2,358 |
Condensed Consolidated Statem_4
Condensed Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 | Mar. 31, 2021 | Dec. 31, 2020 |
Statement of Cash Flows [Abstract] | ||||
Cash and cash equivalents | $ 1,152,014 | $ 1,055,776 | $ 1,119,935 | |
Restricted cash | 10,678 | 10,823 | 18,137 | |
Total cash, cash equivalents, and restricted cash | $ 1,162,692 | $ 1,066,599 | $ 1,138,072 | $ 1,293,947 |
Description of Business and Sum
Description of Business and Summary of Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2022 | |
Accounting Policies [Abstract] | |
Description of Business and Summary of Significant Accounting Policies | Description of Business and Summary of Significant Accounting Policies Description of Business We were founded as Over the Edge Entertainment in Denmark in 2004. We reorganized as a Delaware corporation on May 28, 2009 as Unity Software Inc. (collectively referred to with its wholly owned subsidiaries as "we," "our" or "us"). We provide a comprehensive set of software solutions to create, run and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices, among others. We are headquartered in San Francisco, California and have operations in North America, Europe, Asia Pacific, the Middle East, and Latin America. We market our solutions directly through our online store and field sales operations and indirectly through independent distributors and resellers worldwide. Basis of Presentation and Consolidation We prepared the accompanying unaudited condensed consolidated financial statements in accordance with generally accepted accounting principles in the United States ("GAAP") and applicable rules and regulations of the Securities and Exchange Commission ("SEC") for interim financial reporting. The condensed consolidated financial statements include the accounts of Unity Software Inc. and its wholly owned subsidiaries. We have eliminated all intercompany balances and transactions. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In our opinion, all adjustments, which include normal recurring adjustments necessary for a fair presentation, have been included. The results of operations for the three months ended March 31, 2022 shown in this report are not necessarily indicative of the results to be expected for the full year ending December 31, 2022 or any other period. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on February 22, 2022. There have been no material changes in our significant accounting policies as described in our consolidated financial statements for the year ended December 31, 2021, other than the adoption of accounting pronouncements as described below in Note 2, "Summary of Accounting Pronouncements," of the Notes to Condensed Consolidated Financial Statements. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting period. For us, these estimates include, but are not limited to, revenue recognition, allowances for doubtful accounts, fair values of financial instruments, useful lives of fixed assets, the incremental borrowing rate ("IBR") we use to determine our operating lease liabilities, income taxes, valuation of deferred tax assets and liabilities, valuation of intangible assets, useful lives of intangible assets, assets acquired and liabilities assumed through business combinations, valuation of stock-based compensation, capitalization of software costs and software implementation costs, customer life for capitalized commissions, among others. Actual results could differ from those estimates, and such differences could be material to our financial position and results of operations. |
Summary of Accounting Pronounce
Summary of Accounting Pronouncements | 3 Months Ended |
Mar. 31, 2022 | |
Accounting Policies [Abstract] | |
Summary of Accounting Pronouncements | Summary of Accounting Pronouncements Recent Accounting Pronouncements There have been no recent accounting pronouncements, changes in accounting pronouncements or recently adopted accounting guidance during the three months ended March 31, 2022 that have a significant or will have a potentially significant impact on our financial statements. |
Revenue
Revenue | 3 Months Ended |
Mar. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | Revenue Disaggregation of Revenue Revenue by Source The following table presents our revenue disaggregated by source (in thousands): Three Months Ended March 31, 2022 2021 Create Solutions $ 116,413 $ 70,387 Operate Solutions 184,019 146,578 Strategic Partnerships and Other 19,694 17,807 Total revenue $ 320,126 $ 234,772 Additional information regarding our revenue by source is discussed under the heading “Revenue Recognition” in Note 1, “Description of Business and Summary of Significant Accounting Policies,” of the Notes to Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2021. Revenue by Geographic Area The following table presents our revenue disaggregated by geography, based on the invoice address of our customers (in thousands): Three Months Ended March 31, 2022 2021 United States $ 73,962 $ 57,006 Greater China (1)(2) 43,841 36,549 EMEA (1)(3) 115,304 86,102 APAC (1)(4) 76,689 45,679 Other Americas (1)(5) 10,330 9,436 Total revenue $ 320,126 $ 234,772 (1) No individual country, other than those disclosed above, exceeded 10% of our total revenue for any period presented. (2) Greater China includes China, Hong Kong, and Taiwan. (3) Europe, the Middle East, and Africa ("EMEA") (4) Asia- Pacific , excluding Greater China ("APAC") (5) Canada and Latin America ("Other Americas") Contract Balances Timing of revenue recognition may differ from the timing of invoicing to customers. Contract assets relate to performance completed in advance of scheduled billings. The primary changes in our contract assets and contract liabilities are due to our performance under the contracts and billings. Contract assets (unbilled receivables) included in accounts receivable are recorded when revenue is recognized in advance of customer invoicing. Unbilled receivables totaled $20.5 million and $28.3 million as of March 31, 2022 and December 31, 2021, respectively. Contract liabilities (deferred revenue) relate to payments received in advance of performance under the contract. Revenue recognized during the three months ended March 31, 2022 that was included in the deferred revenue balances at January 1, 2022 was $60.6 million. The satisfaction of performance obligations typically lags behind payments received under contract from customers, which may lead to an increase in our deferred revenue balance over time. Remaining Performance Obligations As of March 31, 2022, we had total remaining performance obligations of $553.5 million, which represents the total contract transaction price allocated to undelivered performance obligations primarily for Create Solutions subscriptions, Enterprise Support, and Strategic Partnership contracts, which are generally recognized over the next one to four years. Transaction price allocated to the remaining performance obligations represents contracted revenue that has not yet been recognized, which includes deferred revenue and unbilled amounts that will be recognized as revenue in future periods. This amount excludes contracts with an original expected term of one year or less and contracts for which we recognize revenue in the amount and in the same period in which we invoice for services performed. We expect to recognize $205.1 million or 37% of this revenue during the next 12 months. We expect to recognize the remaining $348.4 million or 63% of this revenue thereafter. Accounts Receivable We record accounts receivable at the original invoiced amount, net of allowances for credit losses for any potential uncollectible amounts. We make estimates of expected credit losses for the allowance for doubtful accounts based upon our assessment of various factors, including historical experience, the age of the accounts receivable balances, credit quality of our customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect our ability to collect from customers. Accounts receivable deemed uncollectible are charged against the allowance for credit losses when identified. The estimated credit loss allowance is recorded as a general and administrative expense on our condensed consolidated statement of operations. As of March 31, 2022, the allowance for credit losses was $6.3 million. |
Cash Equivalents and Marketable
Cash Equivalents and Marketable Securities | 3 Months Ended |
Mar. 31, 2022 | |
Investments, Debt and Equity Securities [Abstract] | |
Cash Equivalents and Marketable Securities | Cash Equivalents and Marketable Securities Cash equivalents and marketable securities consisted of the following as of March 31, 2022 (in thousands) : Amortized Cost Unrealized Gains Unrealized Losses Fair Value Restricted cash: Restricted cash $ 10,678 $ — $ — $ 10,678 Total restricted cash $ 10,678 $ — $ — $ 10,678 Cash equivalents: Money market funds $ 187,655 $ — $ — $ 187,655 Total cash equivalents $ 187,655 $ — $ — $ 187,655 Marketable securities: Commercial paper $ 96,060 $ — $ — $ 96,060 Asset-backed securities 35,949 — (126) 35,823 Corporate bonds 231,184 — (2,666) 228,518 U.S. treasury securities 235,651 — (1,789) 233,862 Supranational bonds 63,134 — (816) 62,318 Total marketable securities $ 661,978 $ — $ (5,397) $ 656,581 Cash equivalents and marketable securities consisted of the following as of December 31, 2021 (in thousands) : Amortized Cost Unrealized Gains Unrealized Losses Fair Value Restricted cash: Restricted cash $ 10,823 $ — $ — $ 10,823 Total restricted cash $ 10,823 $ — $ — $ 10,823 Cash equivalents: Money market funds $ 73,138 $ — $ — $ 73,138 Total cash equivalents $ 73,138 $ — $ — $ 73,138 Marketable securities: Commercial paper $ 59,792 $ — $ — $ 59,792 Asset-backed securities 40,965 — (23) 40,942 Corporate bonds 237,735 20 (353) 237,402 U.S. treasury securities 272,678 1 (379) 272,300 Supranational bonds 71,121 1 (235) 70,887 Total marketable securities $ 682,291 $ 22 $ (990) $ 681,323 We do not intend to sell any of the securities in an unrealized loss position and we expect to realize the full value of all these investments which may be upon maturity. We did not recognize any credit losses related to our available-for-sale debt securities during the three months ended March 31, 2022 and 2021. The following table summarizes the amortized cost and fair value of our marketable securities as of March 31, 2022, by contractual years to maturity (in thousands): Amortized Cost Fair Value Due within one year $ 487,419 $ 485,480 Due between one and three years 174,559 171,101 Total $ 661,978 $ 656,581 There were no material realized or unrealized gains or losses, either individually or in the aggregate during the three months ended March 31, 2022 and 2021. |
Fair Value Measurements
Fair Value Measurements | 3 Months Ended |
Mar. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements We categorize assets and liabilities recorded or disclosed at fair value on our consolidated balance sheets based upon the level of judgment associated with inputs used to measure their fair value. The categories are as follows: • Level 1—Inputs are unadjusted quoted prices in active markets for identical assets or liabilities. • Level 2—Inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the assets or liabilities, either directly or indirectly through market corroboration, for substantially the full term of the financial instruments. • Level 3—Inputs are unobservable inputs based on our own assumptions used to measure assets and liabilities at fair value. The inputs require significant management judgment or estimation. The following table presents the fair value of our financial assets and liabilities measured at fair value on a recurring basis using the above input categories as of March 31, 2022 (in thousands): Level 1 Level 2 Level 3 Total Restricted cash: Restricted cash $ 10,678 $ — $ — $ 10,678 Total restricted cash $ 10,678 $ — $ — $ 10,678 Cash equivalents: Money market funds $ 187,655 $ — $ — $ 187,655 Total cash equivalents $ 187,655 $ — $ — $ 187,655 Marketable securities: Commercial paper $ — $ 96,060 $ — $ 96,060 Asset-backed securities — 35,823 — 35,823 Corporate bonds — 228,518 — 228,518 U.S. treasury securities — 233,862 — 233,862 Supranational bonds — 62,318 — 62,318 Total marketable securities $ — $ 656,581 $ — $ 656,581 The following table presents the fair value of our financial assets and liabilities measured at fair value on a recurring basis using the above input categories as of December 31, 2021 (in thousands): Level 1 Level 2 Level 3 Total Restricted cash: Restricted cash $ 10,823 $ — $ — $ 10,823 Total restricted cash $ 10,823 $ — $ — $ 10,823 Cash equivalents: Money market funds $ 73,138 $ — $ — $ 73,138 Total cash equivalents $ 73,138 $ — $ — $ 73,138 Marketable securities: Commercial paper $ — $ 59,792 $ — $ 59,792 Asset-backed securities — 40,942 — 40,942 Corporate bonds — 237,402 — 237,402 U.S. treasury securities — 272,300 — 272,300 Supranational bonds — 70,887 — 70,887 Total marketable securities $ — $ 681,323 $ — $ 681,323 Nonrecurring Fair Value Measurements We hold equity investments in certain unconsolidated entities without a readily determinable fair value. These strategic investments represent less than a 20% ownership interest in each of the entities, and we do not have significant influence over or control of the entities. We elected the practical expedient in Financial Accounting Standards Board Accounting Standards Codification Topic 321, Investments-Equity Securities , and measure these investments at cost less any impairment, adjusted for observable price changes, if any. We estimate that the carrying value of the acquired shares represents the fair value of the investment. |
Acquisitions
Acquisitions | 3 Months Ended |
Mar. 31, 2022 | |
Business Combinations [Abstract] | |
Acquisitions | Acquisitions MindKick, Inc. On January 28, 2022, we completed the purchase of MindKick, Inc. ("MindKick") for a total purchase consideration of approximately $46.6 million. This amount was payable in a combination of approximately $26.8 million in cash and the issuance of 169,321 shares of common stock valued at approximately $16.1 million. An additional 42,330 shares of common stock subject to a service-based vesting condition were granted to certain employees of Mindkick; these shares of common stock are accounted for outside of the business combination and will be recognized as post-combination expense. MindKick provides 2D game creation tools and game templates with the goal of providing consumers the ability to create, play, and share their own 2D games on mobile. Prior to the completion of the acquisition, we held a minority investment in MindKick that we accounted for using the equity method of accounting. In circumstances where a business combination is achieved in stages, previously-held equity interests are remeasured at fair value. The remeasured fair value assigned to the previously-held equity interest in MindKick approximates cost, and therefore, no gain or loss was recognized. The following table summarizes the consideration paid for MindKick and the estimated fair values of the assets acquired and liabilities assumed at the acquisition date (in thousands): Consideration: Cash $ 26,761 Common stock issued 16,072 Fair value of previously held interest 3,747 Fair value of total consideration transferred $ 46,580 Recognized amounts of identifiable assets acquired and liabilities assumed: Cash $ 2,789 Intangible assets 7,450 Deferred tax liability (685) Other assets and liabilities, net (14) Total identifiable net assets assumed 9,540 Goodwill (1) 37,040 Total $ 46,580 (1) Goodwill reflects the expected future benefits of certain synergies and acquired assembled workforce, which does not qualify for separate recognition as an identifiable intangible asset. The goodwill balance is not subject to amortization, and it is not deductible for U.S. income tax purposes We recorded $0.8 million in transaction costs associated with the acquisition for the three months ended March 31, 2022. These costs were recorded with general and administrative expenses. The revenue and earnings of the acquired business have been included in our results since the acquisition date and are not material to our consolidated results. |
Goodwill and Intangible Assets
Goodwill and Intangible Assets | 3 Months Ended |
Mar. 31, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and Intangible Assets | Goodwill and Intangible Assets Goodwill The following table presents the changes in the carrying amount of goodwill for the three months ended March 31, 2022 (in thousands): Balance as of December 31, 2021 $ 1,620,127 Goodwill acquired 37,040 Measurement period adjustment 650 Balance as of March 31, 2022 $ 1,657,817 Intangible Assets, Net The following tables present details of our intangible assets, excluding goodwill (in thousands, except for weighted-average useful life): As of March 31, 2022 Weighted-Average (1) Gross Accumulated Net Developed technology 8.8 $ 586,704 $ (69,565) $ 517,139 Customer relationships 2.9 51,121 (20,855) 30,266 Trademark 5.7 60,567 (6,634) 53,933 Contractual relationship 8.0 200,000 (12,194) 187,806 Total intangible assets $ 898,392 $ (109,248) $ 789,144 As of December 31, 2021 Weighted‑Average (1) Gross Accumulated Net Developed technology 8.8 $ 580,204 $ (52,811) $ 527,393 Customer relationships 2.9 50,171 (16,980) 33,191 Trademark 5.7 60,557 (3,937) 56,620 Contractual relationship 8.0 200,000 (2,818) 197,182 Total intangible assets $ 890,932 $ (76,546) $ 814,386 (1) Based on weighted-average useful life established as of the acquisition date. The following table presents the amortization of finite-lived intangible assets included on our condensed consolidated statements of operations and comprehensive loss (in thousands): Three Months Ended March 31, 2022 2021 Amortization expense $ 32,702 $ 4,459 As of March 31, 2022, the estimated future amortization of finite-lived intangible assets for each of the next five years and thereafter was as follows (in thousands): Remainder of 2022 $ 103,715 2023 126,386 2024 121,868 2025 109,928 2026 77,256 Thereafter 249,991 Total $ 789,144 |
Balance Sheet Components
Balance Sheet Components | 3 Months Ended |
Mar. 31, 2022 | |
Property, Plant and Equipment [Abstract] | |
Balance Sheet Components | Balance Sheet Components The following tables provide details of selected balance sheet items (in thousands): As of March 31, December 31, Property and equipment, net: Gross property and equipment Leasehold improvements $ 90,661 $ 84,006 Computer and other hardware 82,878 74,953 Furniture 28,909 27,916 Internally developed software 3,508 3,508 Purchased software 1,013 1,449 Construction in progress 8,250 12,075 Total gross property and equipment 215,219 203,907 Accumulated depreciation and amortization (1) (105,049) (97,801) Property and equipment, net $ 110,170 $ 106,106 (1) The following table presents the depreciation and amortization of property and equipment included on our condensed consolidated statements of operations (in thousands ): Three Months Ended March 31, 2022 2021 Depreciation and amortization expense $ 8,770 $ 7,373 Long-lived Assets, Net, by Geographic Area The following table presents our long-lived assets, net, disaggregated by geography, which consists of our property and equipment, net, but excludes internally developed software and purchased software (in thousands): As of March 31, December 31, United States $ 36,937 $ 36,718 Canada 34,840 31,498 United Kingdom 14,702 15,011 Greater China 4,278 4,300 EMEA, excluding United Kingdom (1) 13,377 12,587 APAC (1) 2,916 3,052 Other Americas, excluding Canada (1) 1,182 945 Total long-lived assets, net $ 108,232 $ 104,111 (1) No individual country, other than those disclosed above, exceeded 10% of our total long-lived assets, net, for any period presented. As of March 31, December 31, Accrued expenses and other current liabilities: Accrued expenses $ 63,466 $ 60,937 Accrued compensation 58,510 83,936 Accrued expenses and other current liabilities $ 121,976 $ 144,873 Sales Commissions We consider internal sales commissions as incremental costs of obtaining the contract with a customer. We apply a practical expedient to expense incremental costs incurred if the period of the benefit is one year or less. Incremental costs that have a period of benefit greater than one year are capitalized and amortized over the estimated period of benefit. Capitalized commissions, net of amortization, are included in other current assets and other assets on our condensed consolidated balance sheets. We capitalized $1.2 million and $2.6 million of sales commissions for the three months ended March 31, 2022 and 2021, respectively. As of March 31, 2022, capitalized commissions, net of amortization, included in other current assets and other assets were $8.2 million and $7.3 million, respectively. As of March 31, 2021, capitalized commissions, net of amortization, included in other current assets and other assets were $3.8 million and $5.1 million, respectively. Capitalized commissions are amortized over the expected period of benefit, which we have determined, based on analysis, to be three years. Amortization of capitalized commissions are included in sales and marketing expenses on our condensed consolidated statements of operations and comprehensive loss. For the three months ended March 31, 2022 and 2021, we amortized $2.3 million and $1.0 million of capitalized commissions, respectively. We did not incur any impairment losses for the three months ended March 31, 2022 and 2021. |
Leases
Leases | 3 Months Ended |
Mar. 31, 2022 | |
Leases [Abstract] | |
Leases | Leases We have operating leases for offices, which have remaining lease terms of less than one year to 9.8 years, some of which include options to extend the lease with renewal terms from one Components of lease expense were as follows (in thousands): Three Months Ended March 31, 2022 2021 Operating lease expense, excluding ROU asset impairment $ 7,620 $ 7,301 Short-term lease expense 270 117 Variable lease expense 1,445 975 Sublease income — (93) Total lease expense $ 9,335 $ 8,300 Other information related to operating leases was as follows (in thousands): Three Months Ended March 31, 2022 2021 Cash paid for amounts included in the measurement of operating lease liabilities $ 5,863 $ 7,840 Operating lease ROU assets obtained in exchange for new operating lease liabilities $ 9,372 $ 18,891 As of March 31, 2022, our operating leases had a weighted-average remaining lease term of 5.8 years and a weighted-average discount rate of 4.3%. As of March 31, 2022, future minimum lease payments under our non-cancellable operating leases were as follows (in thousands): Operating Leases (1) Remainder of 2022 $ 24,118 2023 27,319 2024 23,481 2025 17,828 2026 11,746 Thereafter 32,331 Total future minimum lease payments 136,823 Less: imputed interest 16,019 Present value of lease liabilities $ 120,804 (1) Excludes future minimum payments for leases which have not yet commenced as of March 31, 2022. As of March 31, 2022, we had entered into leases that have not yet commenced with future minimum lease payments of $39.2 million that are not yet reflected on our condensed consolidated balance sheet. These operating leases will commence in 2022 and 2023 with lease terms of 2.1 years to 10.7 years. |
Borrowings
Borrowings | 3 Months Ended |
Mar. 31, 2022 | |
Debt Disclosure [Abstract] | |
Borrowings | Borrowings Convertible Notes In November 2021, we issued an aggregate of $1.7 billion principal amount of 0% Convertible Senior Notes due 2026 (the "2026 Notes"), including the exercise in full by the initial purchasers of their option to purchase up to an additional $225.0 million aggregate principal amount of the 2026 Notes, pursuant to an Indenture dated as of November 19, 2021 (the "Indenture"), between us and U.S. Bank National Association, as trustee. The net proceeds from the issuance of the 2026 Notes were $1.7 billion, net of debt issuance costs and cash used to purchase the capped call transactions ("Capped Call Transactions") discussed below. The debt issuance costs are amortized to interest expense using the straight-line method, which approximates the effective interest method. The 2026 Notes are general unsecured obligations which do not bear regular interest and for which the principal balance will not accrete. We may elect for special interest to accrue on the 2026 Notes as the sole remedy for any failure by us to comply with certain reporting requirements for the first 365 days after the occurrence of such failure under the Indenture. Holders of the 2026 Notes may receive special interest under specified circumstances as outlined in the Indenture. Special interest will accrue for any failure by us to comply with certain reporting requirements during the six-month period beginning on, and including, the date that is six months after the last date of original issuance of the 2026 Notes. Special interest will also accrue if, and for so long as: the restrictive legend on the 2026 Notes has not been removed, the 2026 Notes are assigned a restricted CUSIP number or the 2026 Notes are not otherwise freely tradeable by holders other than our affiliates as of the de-legending deadline date set forth in the Indenture, until the restrictive legend has been removed from the 2026 Notes, the 2026 Notes are assigned an unrestricted CUSIP number and the 2026 Notes are freely tradable. Special interest, if any, will be payable semiannually in arrears on November 15 and May 15 of each year, beginning on May 15, 2022 (if and to the extent that special interest is then payable on the 2026 Notes). The 2026 Notes will mature on November 15, 2026 unless earlier converted, redeemed, or repurchased. The 2026 Notes are convertible into cash, shares of our common stock, or a combination of cash and shares of our common stock, at our election, at an initial conversion rate of 3.2392 shares of common stock per $1,000 principal amount of 2026 Notes, which is equivalent to an initial conversion price of approximately $308.72 per share of our common stock. The conversion rate is subject to customary adjustments for certain events as described in the Indenture governing the 2026 Notes. We may not redeem the Notes prior to November 20, 2024. We may redeem for cash all or any portion of the 2026 Notes, at our option, on or after November 20, 2024 if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30-consecutive-trading-day period (including the last day of such period), ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption. On any such date, the redemption price shall equal 100% of the principal amount of the 2026 Notes to be redeemed, plus accrued and unpaid special interest, if any, up to, but excluding, the redemption date. If we redeem less than all the outstanding 2026 Notes, at least $150.0 million aggregate principal amount of 2026 Notes must be outstanding and not subject to redemption as of, and after giving effect to, delivery of the relevant notice of redemption. No sinking fund is provided for the convertible notes, which means that we are not required to redeem or retire them periodically. Holders of the 2026 Notes may convert all or a portion of their 2026 Notes at their option at any time prior to the close of business on the business day immediately preceding August 15, 2026, in multiples of $1,000 principal amounts, only under the following circumstances: • during any calendar quarter commencing after the calendar quarter ending on March 31, 2022 (and only during such calendar quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the preceding calendar quarter, is greater than or equal to 130% of the applicable conversion price of the 2026 Notes on each such trading day; • during the five business day period after any ten consecutive trading day period in which the trading price per $1,000 principal amount of the 2026 Notes for each trading day of that ten consecutive trading day period was less than 98% of the product of the last reported sale price of our common stock and the applicable conversion rate of the 2026 Notes on each such trading day; • if we call such 2026 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, but only with respect to the 2026 Notes called (or deemed called) for redemption; or • on the occurrence of specified corporate events set forth in the Indenture. On or after August 15, 2026, the 2026 Notes are convertible at any time until the close of business on the second scheduled trading day immediately preceding the maturity date, regardless of the foregoing circumstances. In connection with a make-whole fundamental change, as defined in the Indenture, or in connection with certain corporate events that occur prior to the maturity date or following our issuance of a notice of redemption, in each case as described in the Indenture, we will increase the conversion rate for a holder of the 2026 Notes who elects to convert its 2026 Notes in connection with such a corporate event or during the related redemption period in certain circumstances. Additionally, in the event of a fundamental change, subject to certain limitations described in the Indenture, holders of the 2026 Notes may require us to repurchase all or a portion of the 2026 Notes at a price equal to 100% of the principal amount of 2026 Notes to be repurchased, plus any accrued and unpaid special interest, if any, up to, but excluding, the fundamental change repurchase date. We accounted for the issuance of the 2026 Notes as a single liability measured at its amortized cost, as no other embedded features require bifurcation and recognition as derivatives. As of March 31, 2022 Convertible note: Principal $ 1,725,000 Unamortized debt issuance cost (20,855) Net carrying amount $ 1,704,145 Interest expense related to the amortization of debt issuance costs was $1.1 million for the three months ended March 31, 2022. As of March 31, 2022, the if-converted value of the 2026 Notes did not exceed the principal amount. The sale price for conversion was not satisfied as of March 31, 2022 for the 2026 Notes. The 2026 Notes were not eligible for conversion as of March 31, 2022. Capped Call Transactions In connection with the pricing of the 2026 Notes, we entered into the Capped Call Transactions with certain counterparties at a net cost of $48.1 million with call options totaling approximately 5.6 million of our common shares, and expiration dates beginning on September 18, 2026 and ending on November 12, 2026. The strike price of the Capped Call Transactions is $308.72, and the cap price is initially $343.02 per share of our common stock and is subject to certain adjustments under the terms of the Capped Call Transactions. The Capped Call Transactions are freestanding and are considered separately exercisable from the 2026 Notes. |
Commitment and Contingencies
Commitment and Contingencies | 3 Months Ended |
Mar. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies The following table summarizes our non-cancelable contractual commitments as of March 31, 2022 (in thousands): Total Remainder of 2022 2023‑2024 2025‑2026 Thereafter Purchase commitments (1) $ 656,988 $ 81,637 $ 279,745 $ 295,606 $ — (1) The substantial majority of our purchase commitments are related to agreements with our data center hosting providers. Data Center Hosting Commitments In 2021, we entered into an amended cloud service agreement with an additional term of five years beginning on the amendment date and an increase in annual commitments over the contract term. Under the original and amended agreements, we were granted access to use certain cloud services. Minimum annual commitments increase annually over the term of the agreement. The aggregate value of all annual minimum commitments over the amended contract term is $700.0 million over five years. Total spend under the original and amended cloud service agreements for the three months ended March 31, 2022 and 2021 was approximately $32.9 million and $25.1 million, respectively. We expect to meet our remaining commitments. Legal Matters In the normal course of business, we are subject to various legal matters. We accrue a liability when management believes both that it is probable that a liability has been incurred and that the amount of loss can be reasonably estimated. We also disclose material contingencies when we believe a loss is not probable but reasonably possible. Legal costs related to such potential losses are expensed as incurred. In addition, recoveries are shown as a reduction in legal costs in the period in which they are realized. With respect to our outstanding matters, based on our current knowledge, we believe that the resolution of such matters will not, either individually or in aggregate, have a material adverse effect on our business or our consolidated financial statements. However, litigation is inherently uncertain, and the outcome of these matters cannot be predicted with certainty. Accordingly, cash flows or results of operations could be materially affected in any particular period by the resolution of one or more of these matters. Indemnifications In the ordinary course of business, we may provide indemnifications of varying scope and terms to customers, vendors, lessors, investors, directors, officers, employees and other parties with respect to certain matters. Indemnification may include losses from our breach of such agreements, services we provide, or third-party intellectual property infringement claims. These indemnifications may survive termination of the underlying agreement and the maximum potential amount of future indemnification payments may not be subject to a cap. As of March 31, 2022, there were no known events or circumstances that have resulted in a material indemnification liability to us and we did not incur material costs to defend lawsuits or settle claims related to these indemnifications. Letters of Credit We had $10.7 million and $10.8 million of secured letters of credit outstanding as of March 31, 2022 and December 31, 2021, respectively. These primarily relate to our office space leases and are fully collateralized by certificates of deposit which we record in restricted cash on our condensed consolidated balance sheets based on the term of the remaining restriction. |
Stock-Based Compensation
Stock-Based Compensation | 3 Months Ended |
Mar. 31, 2022 | |
Share-based Payment Arrangement [Abstract] | |
Stock-Based Compensation | Stock‑Based Compensation We recorded stock-based compensation expense related to grants to employees, including those in connection with modified awards, on our condensed consolidated statements of operations as follows (in thousands): Three Months Ended March 31, 2022 2021 Cost of revenue $ 8,794 $ 5,117 Research and development 55,253 31,650 Sales and marketing 23,834 12,037 General and administrative 15,546 17,757 Total stock-based compensation expense $ 103,427 $ 66,561 In March 2021, we entered into a separation agreement with our former Chief Financial Officer. The agreement provided for payment of a one-time lump-sum severance benefit of $0.3 million, payment for coverage under COBRA and modification of the equity awards. Incremental stock-based compensation expense totaled $12.6 million, of which $2.1 million, along with the one-time lump-sum severance benefit of $0.3 million, were recorded in general and administrative expense in the three months ended March 31, 2021. The remaining $10.5 million of stock-based compensation expense was recorded in general and administrative expense in the three months ended June 30, 2021. Stock Options A summary of our stock option activity under the 2009 Stock Plan, 2019 Stock Plan, and 2020 Equity Incentive Plan (the "2020 Plan") is as follows: Options Outstanding Stock Weighted-Average Weighted-Average Balance as of December 31, 2021 29,226,041 $ 13.28 6.26 Granted 1,121,855 $ 89.01 Exercised (1,952,058) $ 5.84 Forfeited, cancelled, or expired (329,184) $ 32.16 Balance as of March 31, 2022 28,066,654 $ 16.60 6.18 The calculated grant-date fair value of stock options granted was estimated using the Black-Scholes option-pricing model with the following assumptions: Three Months Ended March 31, 2022 2021 Expected dividend yield — — Risk-free interest rate 1.7% 0.9% Expected volatility 33.8% 36.0% Expected term (in years) 6.25 6.25 Fair value of underlying common stock $89.01 $102.80 - $108.10 Restricted Stock Units A summary of our RSU activity under the 2019 Stock Plan and 2020 Plan is as follows: Unvested RSUs Number of Weighted-Average Unvested as of December 31, 2021 13,696,836 $ 85.96 Granted 3,332,753 $ 89.09 Vested (957,467) $ 87.13 Forfeited (443,328) $ 79.94 Unvested as of March 31, 2022 15,628,794 $ 86.73 Employee Stock Purchase Plan In determining the fair value of the shares subject to our Employee Stock Purchase Plan (the "ESPP"), we use the Black-Scholes option pricing model that employs the following weighted-average assumptions: Three Months Ended March 31, 2022 Expected dividend yield — Risk-free interest rate 0.6% Expected volatility 40.0% Expected term (in years) 0.50 Estimated fair value $27.42 Additional information related to the ESPP is provided below (in thousands, except per share amounts): Three Months Ended March 31, 2022 Share issued under the ESPP 207,986 Weighted-average price per share issued $90.48 No shares were granted or issued under the ESPP during the three months ended March 31, 2021. |
Income Taxes
Income Taxes | 3 Months Ended |
Mar. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes Our tax provision for interim periods is determined using an estimated annual effective tax rate, adjusted for discrete items arising in that quarter. In each quarter, we update the estimated annual effective tax rate and make a year-to-date adjustment to the provision. The estimated annual effective tax rate is subject to volatility due to several factors, including variability in accurately predicting our pre-tax income or loss and the mix of jurisdictions to which they relate, intercompany transactions, changes in how we do business, and tax law developments. Our effective tax rate for the three months ended March 31, 2022 differs from the U.S. federal statutory tax rate of 21% primarily due to foreign earnings being taxed at different tax rates, losses that cannot be benefited due to the valuation allowance on U.S., Denmark, and U.K. entities, and base-erosion and anti-abuse tax ("BEAT") mainly arising as a result of mandatory R&D capitalization under IRC Section 174. Our effective tax rate for the three months ended March 31, 2021 differs from the U.S. federal statutory tax rate of 21% primarily due to foreign earnings being taxed at different tax rates, losses that cannot be benefited due to the valuation allowance on U.S. and Denmark entities, the tax benefit from stock-based compensation activities during the period, and the tax expense related to an intercompany transaction with our subsidiary in Israel. The realization of deferred tax assets is dependent upon the generation of sufficient taxable income of the appropriate character in future periods. We regularly assess the ability to realize our deferred tax assets and establish a valuation allowance if it is more-likely-than-not that some portion of the deferred tax assets will not be realized. We weigh all available positive and negative evidence, including our earnings history and results of recent operations, scheduled reversals of deferred tax liabilities, projected future taxable income, and tax planning strategies. Due to the weight of objectively verifiable negative evidence, including our history of losses, we believe that it is more likely than not that our U.S. federal, certain state, Denmark, U.K., and certain non-U.S. jurisdictions deferred tax assets will not be realized as of March 31, 2022 and December 31, 2021, and as such, we have maintained a full valuation allowance against such deferred tax assets. As of March 31, 2022, we had $121.8 million of gross unrecognized tax benefits, of which $11.4 million would impact the effective tax rate, if recognized. It is reasonably possible that the amount of unrecognized tax benefits as of March 31, 2022 could increase or decrease significantly due to the lapse of statutes of limitations within the next 12 months. As a result, the amount of unrecognized tax benefits may decrease by as much as $1.8 million. We believe that we have adequately provided for any reasonably foreseeable outcome related to our tax audits and that any settlement will not have a material impact on our financial condition and operating results at this time. |
Net Loss per Share of Common St
Net Loss per Share of Common Stock | 3 Months Ended |
Mar. 31, 2022 | |
Earnings Per Share [Abstract] | |
Net Loss per Share of Common Stock | Net Loss per Share of Common Stock Basic net loss per share attributable to our common stockholders is computed using the weighted-average number of common shares outstanding during the period, less shares subject to repurchase. Diluted net loss per share is computed by giving effect to all potentially dilutive common stock outstanding for the period, including stock options, stock under the ESPP, and RSUs, using the treasury stock method, and the 2026 Notes, using the if-converted method. Diluted net loss per share is the same as basic net loss per share for all periods presented because the effects of potentially dilutive items were antidilutive given our net loss in each period presented. The following table presents the calculation of basic and diluted net loss per share (in thousands, except per share data): Three Months Ended March 31, 2022 2021 Basic and diluted net loss per share Numerator: Net loss attributable to our common stockholders $ (177,555) $ (107,460) Denominator: Weighted-average common shares used in per share computation, basic and diluted 294,341 276,068 Net loss per share, basic and diluted $ (0.60) $ (0.39) The following table presents the forms of antidilutive potential common shares excluded from the computation of diluted net loss per share for the following periods (in thousands): Three Months Ended March 31, 2022 2021 Convertible notes 12,441 — Stock options 28,067 36,838 Unvested RSUs 15,629 11,263 |
Description of Business and S_2
Description of Business and Summary of Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation and ConsolidationWe prepared the accompanying unaudited condensed consolidated financial statements in accordance with generally accepted accounting principles in the United States ("GAAP") and applicable rules and regulations of the Securities and Exchange Commission ("SEC") for interim financial reporting. |
Consolidation | The condensed consolidated financial statements include the accounts of Unity Software Inc. and its wholly owned subsidiaries. We have eliminated all intercompany balances and transactions. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In our opinion, all adjustments, which include normal recurring adjustments necessary for a fair presentation, have been included. The results of operations for the three months ended March 31, 2022 shown in this report are not necessarily indicative of the results to be expected for the full year ending December 31, 2022 or any other period. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on February 22, 2022. |
Use of Estimates | Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting period. For us, these estimates include, but are not limited to, revenue recognition, allowances for doubtful accounts, fair values of financial instruments, useful lives of fixed assets, the incremental borrowing rate ("IBR") we use to determine our operating lease liabilities, income taxes, valuation of deferred tax assets and liabilities, valuation of intangible assets, useful lives of intangible assets, assets acquired and liabilities assumed through business combinations, valuation of stock-based compensation, capitalization of software costs and software implementation costs, customer life for capitalized commissions, among others. Actual results could differ from those estimates, and such differences could be material to our financial position and results of operations. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements There have been no recent accounting pronouncements, changes in accounting pronouncements or recently adopted accounting guidance during the three months ended March 31, 2022 that have a significant or will have a potentially significant impact on our financial statements. |
Revenue Recognition | Contract Balances Timing of revenue recognition may differ from the timing of invoicing to customers. Contract assets relate to performance completed in advance of scheduled billings. The primary changes in our contract assets and contract liabilities are due to our performance under the contracts and billings. |
Accounts Receivable | Accounts ReceivableWe record accounts receivable at the original invoiced amount, net of allowances for credit losses for any potential uncollectible amounts. We make estimates of expected credit losses for the allowance for doubtful accounts based upon our assessment of various factors, including historical experience, the age of the accounts receivable balances, credit quality of our customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect our ability to collect from customers. Accounts receivable deemed uncollectible are charged against the allowance for credit losses when identified. |
Revenue (Tables)
Revenue (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Schedule of Revenue by Source | The following table presents our revenue disaggregated by source (in thousands): Three Months Ended March 31, 2022 2021 Create Solutions $ 116,413 $ 70,387 Operate Solutions 184,019 146,578 Strategic Partnerships and Other 19,694 17,807 Total revenue $ 320,126 $ 234,772 |
Schedule of Revenue by Geographic Area | The following table presents our revenue disaggregated by geography, based on the invoice address of our customers (in thousands): Three Months Ended March 31, 2022 2021 United States $ 73,962 $ 57,006 Greater China (1)(2) 43,841 36,549 EMEA (1)(3) 115,304 86,102 APAC (1)(4) 76,689 45,679 Other Americas (1)(5) 10,330 9,436 Total revenue $ 320,126 $ 234,772 (1) No individual country, other than those disclosed above, exceeded 10% of our total revenue for any period presented. (2) Greater China includes China, Hong Kong, and Taiwan. (3) Europe, the Middle East, and Africa ("EMEA") (4) Asia- Pacific , excluding Greater China ("APAC") (5) Canada and Latin America ("Other Americas") |
Cash Equivalents and Marketab_2
Cash Equivalents and Marketable Securities (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Investments, Debt and Equity Securities [Abstract] | |
Schedule of Cash Equivalents and Marketable Securities | Cash equivalents and marketable securities consisted of the following as of March 31, 2022 (in thousands) : Amortized Cost Unrealized Gains Unrealized Losses Fair Value Restricted cash: Restricted cash $ 10,678 $ — $ — $ 10,678 Total restricted cash $ 10,678 $ — $ — $ 10,678 Cash equivalents: Money market funds $ 187,655 $ — $ — $ 187,655 Total cash equivalents $ 187,655 $ — $ — $ 187,655 Marketable securities: Commercial paper $ 96,060 $ — $ — $ 96,060 Asset-backed securities 35,949 — (126) 35,823 Corporate bonds 231,184 — (2,666) 228,518 U.S. treasury securities 235,651 — (1,789) 233,862 Supranational bonds 63,134 — (816) 62,318 Total marketable securities $ 661,978 $ — $ (5,397) $ 656,581 Cash equivalents and marketable securities consisted of the following as of December 31, 2021 (in thousands) : Amortized Cost Unrealized Gains Unrealized Losses Fair Value Restricted cash: Restricted cash $ 10,823 $ — $ — $ 10,823 Total restricted cash $ 10,823 $ — $ — $ 10,823 Cash equivalents: Money market funds $ 73,138 $ — $ — $ 73,138 Total cash equivalents $ 73,138 $ — $ — $ 73,138 Marketable securities: Commercial paper $ 59,792 $ — $ — $ 59,792 Asset-backed securities 40,965 — (23) 40,942 Corporate bonds 237,735 20 (353) 237,402 U.S. treasury securities 272,678 1 (379) 272,300 Supranational bonds 71,121 1 (235) 70,887 Total marketable securities $ 682,291 $ 22 $ (990) $ 681,323 |
Schedule of Cash Equivalents | Cash equivalents and marketable securities consisted of the following as of March 31, 2022 (in thousands) : Amortized Cost Unrealized Gains Unrealized Losses Fair Value Restricted cash: Restricted cash $ 10,678 $ — $ — $ 10,678 Total restricted cash $ 10,678 $ — $ — $ 10,678 Cash equivalents: Money market funds $ 187,655 $ — $ — $ 187,655 Total cash equivalents $ 187,655 $ — $ — $ 187,655 Marketable securities: Commercial paper $ 96,060 $ — $ — $ 96,060 Asset-backed securities 35,949 — (126) 35,823 Corporate bonds 231,184 — (2,666) 228,518 U.S. treasury securities 235,651 — (1,789) 233,862 Supranational bonds 63,134 — (816) 62,318 Total marketable securities $ 661,978 $ — $ (5,397) $ 656,581 Cash equivalents and marketable securities consisted of the following as of December 31, 2021 (in thousands) : Amortized Cost Unrealized Gains Unrealized Losses Fair Value Restricted cash: Restricted cash $ 10,823 $ — $ — $ 10,823 Total restricted cash $ 10,823 $ — $ — $ 10,823 Cash equivalents: Money market funds $ 73,138 $ — $ — $ 73,138 Total cash equivalents $ 73,138 $ — $ — $ 73,138 Marketable securities: Commercial paper $ 59,792 $ — $ — $ 59,792 Asset-backed securities 40,965 — (23) 40,942 Corporate bonds 237,735 20 (353) 237,402 U.S. treasury securities 272,678 1 (379) 272,300 Supranational bonds 71,121 1 (235) 70,887 Total marketable securities $ 682,291 $ 22 $ (990) $ 681,323 |
Schedule of Maturities for Marketable Securities | The following table summarizes the amortized cost and fair value of our marketable securities as of March 31, 2022, by contractual years to maturity (in thousands): Amortized Cost Fair Value Due within one year $ 487,419 $ 485,480 Due between one and three years 174,559 171,101 Total $ 661,978 $ 656,581 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Schedule of Fair Value of Assets Measured on Recurring Basis | The following table presents the fair value of our financial assets and liabilities measured at fair value on a recurring basis using the above input categories as of March 31, 2022 (in thousands): Level 1 Level 2 Level 3 Total Restricted cash: Restricted cash $ 10,678 $ — $ — $ 10,678 Total restricted cash $ 10,678 $ — $ — $ 10,678 Cash equivalents: Money market funds $ 187,655 $ — $ — $ 187,655 Total cash equivalents $ 187,655 $ — $ — $ 187,655 Marketable securities: Commercial paper $ — $ 96,060 $ — $ 96,060 Asset-backed securities — 35,823 — 35,823 Corporate bonds — 228,518 — 228,518 U.S. treasury securities — 233,862 — 233,862 Supranational bonds — 62,318 — 62,318 Total marketable securities $ — $ 656,581 $ — $ 656,581 The following table presents the fair value of our financial assets and liabilities measured at fair value on a recurring basis using the above input categories as of December 31, 2021 (in thousands): Level 1 Level 2 Level 3 Total Restricted cash: Restricted cash $ 10,823 $ — $ — $ 10,823 Total restricted cash $ 10,823 $ — $ — $ 10,823 Cash equivalents: Money market funds $ 73,138 $ — $ — $ 73,138 Total cash equivalents $ 73,138 $ — $ — $ 73,138 Marketable securities: Commercial paper $ — $ 59,792 $ — $ 59,792 Asset-backed securities — 40,942 — 40,942 Corporate bonds — 237,402 — 237,402 U.S. treasury securities — 272,300 — 272,300 Supranational bonds — 70,887 — 70,887 Total marketable securities $ — $ 681,323 $ — $ 681,323 |
Acquisitions (Tables)
Acquisitions (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Business Combinations [Abstract] | |
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed | The following table summarizes the consideration paid for MindKick and the estimated fair values of the assets acquired and liabilities assumed at the acquisition date (in thousands): Consideration: Cash $ 26,761 Common stock issued 16,072 Fair value of previously held interest 3,747 Fair value of total consideration transferred $ 46,580 Recognized amounts of identifiable assets acquired and liabilities assumed: Cash $ 2,789 Intangible assets 7,450 Deferred tax liability (685) Other assets and liabilities, net (14) Total identifiable net assets assumed 9,540 Goodwill (1) 37,040 Total $ 46,580 (1) Goodwill reflects the expected future benefits of certain synergies and acquired assembled workforce, which does not qualify for separate recognition as an identifiable intangible asset. The goodwill balance is not subject to amortization, and it is not deductible for U.S. income tax purposes |
Goodwill and Intangible Assets
Goodwill and Intangible Assets (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Goodwill | The following table presents the changes in the carrying amount of goodwill for the three months ended March 31, 2022 (in thousands): Balance as of December 31, 2021 $ 1,620,127 Goodwill acquired 37,040 Measurement period adjustment 650 Balance as of March 31, 2022 $ 1,657,817 |
Schedule of Intangible Assets | The following tables present details of our intangible assets, excluding goodwill (in thousands, except for weighted-average useful life): As of March 31, 2022 Weighted-Average (1) Gross Accumulated Net Developed technology 8.8 $ 586,704 $ (69,565) $ 517,139 Customer relationships 2.9 51,121 (20,855) 30,266 Trademark 5.7 60,567 (6,634) 53,933 Contractual relationship 8.0 200,000 (12,194) 187,806 Total intangible assets $ 898,392 $ (109,248) $ 789,144 As of December 31, 2021 Weighted‑Average (1) Gross Accumulated Net Developed technology 8.8 $ 580,204 $ (52,811) $ 527,393 Customer relationships 2.9 50,171 (16,980) 33,191 Trademark 5.7 60,557 (3,937) 56,620 Contractual relationship 8.0 200,000 (2,818) 197,182 Total intangible assets $ 890,932 $ (76,546) $ 814,386 (1) Based on weighted-average useful life established as of the acquisition date. |
Schedule of Finite-lived Intangible Assets Amortization Expense | The following table presents the amortization of finite-lived intangible assets included on our condensed consolidated statements of operations and comprehensive loss (in thousands): Three Months Ended March 31, 2022 2021 Amortization expense $ 32,702 $ 4,459 |
Schedule of Finite-Lived Intangible Assets Future Amortization Expense | As of March 31, 2022, the estimated future amortization of finite-lived intangible assets for each of the next five years and thereafter was as follows (in thousands): Remainder of 2022 $ 103,715 2023 126,386 2024 121,868 2025 109,928 2026 77,256 Thereafter 249,991 Total $ 789,144 |
Balance Sheet Components (Table
Balance Sheet Components (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Property, Plant and Equipment [Abstract] | |
Schedule of Property and Equipment | The following tables provide details of selected balance sheet items (in thousands): As of March 31, December 31, Property and equipment, net: Gross property and equipment Leasehold improvements $ 90,661 $ 84,006 Computer and other hardware 82,878 74,953 Furniture 28,909 27,916 Internally developed software 3,508 3,508 Purchased software 1,013 1,449 Construction in progress 8,250 12,075 Total gross property and equipment 215,219 203,907 Accumulated depreciation and amortization (1) (105,049) (97,801) Property and equipment, net $ 110,170 $ 106,106 (1) The following table presents the depreciation and amortization of property and equipment included on our condensed consolidated statements of operations (in thousands ): Three Months Ended March 31, 2022 2021 Depreciation and amortization expense $ 8,770 $ 7,373 |
Schedule of Long-lived Assets by Geographic Areas | The following table presents our long-lived assets, net, disaggregated by geography, which consists of our property and equipment, net, but excludes internally developed software and purchased software (in thousands): As of March 31, December 31, United States $ 36,937 $ 36,718 Canada 34,840 31,498 United Kingdom 14,702 15,011 Greater China 4,278 4,300 EMEA, excluding United Kingdom (1) 13,377 12,587 APAC (1) 2,916 3,052 Other Americas, excluding Canada (1) 1,182 945 Total long-lived assets, net $ 108,232 $ 104,111 (1) No individual country, other than those disclosed above, exceeded 10% of our total long-lived assets, net, for any period presented. |
Schedule of Accrued Expenses and Current Liabilities | As of March 31, December 31, Accrued expenses and other current liabilities: Accrued expenses $ 63,466 $ 60,937 Accrued compensation 58,510 83,936 Accrued expenses and other current liabilities $ 121,976 $ 144,873 |
Leases (Tables)
Leases (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Leases [Abstract] | |
Schedule of Lease Cost | Components of lease expense were as follows (in thousands): Three Months Ended March 31, 2022 2021 Operating lease expense, excluding ROU asset impairment $ 7,620 $ 7,301 Short-term lease expense 270 117 Variable lease expense 1,445 975 Sublease income — (93) Total lease expense $ 9,335 $ 8,300 Other information related to operating leases was as follows (in thousands): Three Months Ended March 31, 2022 2021 Cash paid for amounts included in the measurement of operating lease liabilities $ 5,863 $ 7,840 Operating lease ROU assets obtained in exchange for new operating lease liabilities $ 9,372 $ 18,891 |
Schedule of Future Minimum Lease Payments | As of March 31, 2022, future minimum lease payments under our non-cancellable operating leases were as follows (in thousands): Operating Leases (1) Remainder of 2022 $ 24,118 2023 27,319 2024 23,481 2025 17,828 2026 11,746 Thereafter 32,331 Total future minimum lease payments 136,823 Less: imputed interest 16,019 Present value of lease liabilities $ 120,804 (1) Excludes future minimum payments for leases which have not yet commenced as of March 31, 2022. |
Borrowings (Tables)
Borrowings (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Debt Disclosure [Abstract] | |
Summary of Convertible Debt | As of March 31, 2022 Convertible note: Principal $ 1,725,000 Unamortized debt issuance cost (20,855) Net carrying amount $ 1,704,145 |
Commitment and Contingencies (T
Commitment and Contingencies (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Maturities of Future Purchase Obligations | The following table summarizes our non-cancelable contractual commitments as of March 31, 2022 (in thousands): Total Remainder of 2022 2023‑2024 2025‑2026 Thereafter Purchase commitments (1) $ 656,988 $ 81,637 $ 279,745 $ 295,606 $ — (1) The substantial majority of our purchase commitments are related to agreements with our data center hosting providers. |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Share-based Payment Arrangement [Abstract] | |
Schedule of Stock-Based Compensation Expense | We recorded stock-based compensation expense related to grants to employees, including those in connection with modified awards, on our condensed consolidated statements of operations as follows (in thousands): Three Months Ended March 31, 2022 2021 Cost of revenue $ 8,794 $ 5,117 Research and development 55,253 31,650 Sales and marketing 23,834 12,037 General and administrative 15,546 17,757 Total stock-based compensation expense $ 103,427 $ 66,561 |
Schedule of Stock Options | A summary of our stock option activity under the 2009 Stock Plan, 2019 Stock Plan, and 2020 Equity Incentive Plan (the "2020 Plan") is as follows: Options Outstanding Stock Weighted-Average Weighted-Average Balance as of December 31, 2021 29,226,041 $ 13.28 6.26 Granted 1,121,855 $ 89.01 Exercised (1,952,058) $ 5.84 Forfeited, cancelled, or expired (329,184) $ 32.16 Balance as of March 31, 2022 28,066,654 $ 16.60 6.18 |
Summary of Valuation Assumptions of Stock Options | The calculated grant-date fair value of stock options granted was estimated using the Black-Scholes option-pricing model with the following assumptions: Three Months Ended March 31, 2022 2021 Expected dividend yield — — Risk-free interest rate 1.7% 0.9% Expected volatility 33.8% 36.0% Expected term (in years) 6.25 6.25 Fair value of underlying common stock $89.01 $102.80 - $108.10 |
Summary of Restricted Stock Unit Activity | A summary of our RSU activity under the 2019 Stock Plan and 2020 Plan is as follows: Unvested RSUs Number of Weighted-Average Unvested as of December 31, 2021 13,696,836 $ 85.96 Granted 3,332,753 $ 89.09 Vested (957,467) $ 87.13 Forfeited (443,328) $ 79.94 Unvested as of March 31, 2022 15,628,794 $ 86.73 |
Summary of Valuation Assumptions of Employee Stock Purchase Plans | In determining the fair value of the shares subject to our Employee Stock Purchase Plan (the "ESPP"), we use the Black-Scholes option pricing model that employs the following weighted-average assumptions: Three Months Ended March 31, 2022 Expected dividend yield — Risk-free interest rate 0.6% Expected volatility 40.0% Expected term (in years) 0.50 Estimated fair value $27.42 |
Summary of Employee Stock Purchase Plan | Additional information related to the ESPP is provided below (in thousands, except per share amounts): Three Months Ended March 31, 2022 Share issued under the ESPP 207,986 Weighted-average price per share issued $90.48 |
Net Loss per Share of Common _2
Net Loss per Share of Common Stock (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Earnings Per Share [Abstract] | |
Schedule of Basic and Diluted Earnings Per Share | The following table presents the calculation of basic and diluted net loss per share (in thousands, except per share data): Three Months Ended March 31, 2022 2021 Basic and diluted net loss per share Numerator: Net loss attributable to our common stockholders $ (177,555) $ (107,460) Denominator: Weighted-average common shares used in per share computation, basic and diluted 294,341 276,068 Net loss per share, basic and diluted $ (0.60) $ (0.39) |
Schedule of Antidilutive Securities Excluded from Computation of Diluted Earnings Per Share | The following table presents the forms of antidilutive potential common shares excluded from the computation of diluted net loss per share for the following periods (in thousands): Three Months Ended March 31, 2022 2021 Convertible notes 12,441 — Stock options 28,067 36,838 Unvested RSUs 15,629 11,263 |
Revenue - Disaggregation of Rev
Revenue - Disaggregation of Revenue By Source (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Disaggregation of Revenue [Line Items] | ||
Revenue | $ 320,126 | $ 234,772 |
Create Solutions | ||
Disaggregation of Revenue [Line Items] | ||
Revenue | 116,413 | 70,387 |
Operate Solutions | ||
Disaggregation of Revenue [Line Items] | ||
Revenue | 184,019 | 146,578 |
Strategic Partnerships and Other | ||
Disaggregation of Revenue [Line Items] | ||
Revenue | $ 19,694 | $ 17,807 |
Revenue - Disaggregation of R_2
Revenue - Disaggregation of Revenue by Geographic Area (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Disaggregation of Revenue [Line Items] | ||
Revenue | $ 320,126 | $ 234,772 |
United States | ||
Disaggregation of Revenue [Line Items] | ||
Revenue | 73,962 | 57,006 |
Greater China | ||
Disaggregation of Revenue [Line Items] | ||
Revenue | 43,841 | 36,549 |
EMEA | ||
Disaggregation of Revenue [Line Items] | ||
Revenue | 115,304 | 86,102 |
APAC | ||
Disaggregation of Revenue [Line Items] | ||
Revenue | 76,689 | 45,679 |
Other Americas | ||
Disaggregation of Revenue [Line Items] | ||
Revenue | $ 10,330 | $ 9,436 |
Revenue - Contract Balances & A
Revenue - Contract Balances & Accounts Receivable (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2022 | Dec. 31, 2021 | |
Revenue from Contract with Customer [Abstract] | |||
Unbilled receivables | $ 20,500 | $ 28,300 | |
Revenue recognized | $ 60,600 | ||
Accounts receivable, allowances | $ 6,259 | $ 5,447 |
Revenue - Remaining Performance
Revenue - Remaining Performance Obligations (Details) $ in Millions | Mar. 31, 2022USD ($) |
Disaggregation of Revenue [Line Items] | |
Revenue, remaining performance obligation, amount | $ 553.5 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-04-01 | |
Disaggregation of Revenue [Line Items] | |
Revenue, remaining performance obligation, amount | $ 205.1 |
Revenue, remaining performance obligation, percentage | 37.00% |
Recognition period | 12 months |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01 | |
Disaggregation of Revenue [Line Items] | |
Revenue, remaining performance obligation, amount | $ 348.4 |
Revenue, remaining performance obligation, percentage | 63.00% |
Recognition period |
Cash Equivalents and Marketab_3
Cash Equivalents and Marketable Securities - Schedule of Cash Equivalents and Marketable Securities (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Debt Securities, Available-for-sale [Line Items] | ||
Restricted cash | $ 10,678 | $ 10,823 |
Restricted cash, fair value | 10,678 | 10,823 |
Cash equivalents, amortized cost | 187,655 | 73,138 |
Cash equivalents | 187,655 | 73,138 |
Amortized Cost | 661,978 | 682,291 |
Unrealized Gains | 0 | 22 |
Unrealized Losses | (5,397) | (990) |
Marketable securities | 656,581 | 681,323 |
Money market funds | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cash equivalents, amortized cost | 187,655 | 73,138 |
Cash equivalents | 187,655 | 73,138 |
Commercial paper | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 96,060 | 59,792 |
Unrealized Gains | 0 | 0 |
Unrealized Losses | 0 | 0 |
Marketable securities | 96,060 | 59,792 |
Asset-backed securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 35,949 | 40,965 |
Unrealized Gains | 0 | 0 |
Unrealized Losses | (126) | (23) |
Marketable securities | 35,823 | 40,942 |
Corporate bonds | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 231,184 | 237,735 |
Unrealized Gains | 0 | 20 |
Unrealized Losses | (2,666) | (353) |
Marketable securities | 228,518 | 237,402 |
U.S. treasury securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 235,651 | 272,678 |
Unrealized Gains | 0 | 1 |
Unrealized Losses | (1,789) | (379) |
Marketable securities | 233,862 | 272,300 |
Supranational bonds | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 63,134 | 71,121 |
Unrealized Gains | 0 | 1 |
Unrealized Losses | (816) | (235) |
Marketable securities | $ 62,318 | $ 70,887 |
Cash Equivalents and Marketab_4
Cash Equivalents and Marketable Securities - Maturity of Marketable Securities (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Amortized Cost | ||
Due within one year | $ 487,419 | |
Due between one and three years | 174,559 | |
Amortized Cost | 661,978 | $ 682,291 |
Fair Value | ||
Due within one year | 485,480 | |
Due between one and three years | 171,101 | |
Fair Value | $ 656,581 | $ 681,323 |
Fair Value Measurements (Detail
Fair Value Measurements (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Dec. 31, 2021 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Restricted cash, fair value | $ 10,678 | $ 10,823 |
Cash equivalents, fair value | 187,655 | 73,138 |
Marketable securities | $ 656,581 | 681,323 |
Maximum | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Ownership interest less than | 20.00% | |
Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Restricted cash, fair value | $ 10,678 | 10,823 |
Cash equivalents, fair value | 187,655 | 73,138 |
Marketable securities | 656,581 | 681,323 |
Commercial paper | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 96,060 | 59,792 |
Commercial paper | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 96,060 | 59,792 |
Asset-backed securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 35,823 | 40,942 |
Asset-backed securities | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 35,823 | 40,942 |
Corporate bonds | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 228,518 | 237,402 |
U.S. treasury securities | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 233,862 | 272,300 |
Supranational bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 62,318 | 70,887 |
Supranational bonds | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 62,318 | 70,887 |
Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents, fair value | 187,655 | 73,138 |
Money market funds | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents, fair value | 187,655 | 73,138 |
Level 1 | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Restricted cash, fair value | 10,678 | 10,823 |
Cash equivalents, fair value | 187,655 | 73,138 |
Marketable securities | 0 | 0 |
Level 1 | Commercial paper | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Level 1 | Asset-backed securities | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Level 1 | Corporate bonds | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Level 1 | U.S. treasury securities | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Level 1 | Supranational bonds | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Level 1 | Money market funds | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents, fair value | 187,655 | 73,138 |
Level 2 | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Restricted cash, fair value | 0 | 0 |
Cash equivalents, fair value | 0 | 0 |
Marketable securities | 656,581 | 681,323 |
Level 2 | Commercial paper | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 96,060 | 59,792 |
Level 2 | Asset-backed securities | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 35,823 | 40,942 |
Level 2 | Corporate bonds | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 228,518 | 237,402 |
Level 2 | U.S. treasury securities | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 233,862 | 272,300 |
Level 2 | Supranational bonds | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 62,318 | 70,887 |
Level 2 | Money market funds | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents, fair value | 0 | 0 |
Level 3 | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Restricted cash, fair value | 0 | 0 |
Cash equivalents, fair value | 0 | 0 |
Marketable securities | 0 | 0 |
Level 3 | Commercial paper | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Level 3 | Asset-backed securities | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Level 3 | Corporate bonds | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Level 3 | U.S. treasury securities | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Level 3 | Supranational bonds | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Level 3 | Money market funds | Fair Value, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents, fair value | $ 0 | $ 0 |
Acquisitions - 2022 Acquisition
Acquisitions - 2022 Acquisitions (Details) - USD ($) $ in Thousands | Jan. 28, 2022 | Mar. 31, 2022 | Mar. 31, 2021 |
Business Acquisition [Line Items] | |||
Fair value of common stock issued as consideration for business acquisitions | $ 16,072 | $ 0 | |
MindKick, Inc. | |||
Business Acquisition [Line Items] | |||
Consideration transferred | $ 46,580 | ||
Cash consideration transferred | $ 26,761 | ||
Shares issued as consideration (in shares) | 169,321 | ||
Fair value of common stock issued as consideration for business acquisitions | $ 16,072 | ||
Additional shares (in shares) | 42,330 | ||
Transaction costs | $ 800 |
Acquisitions - Summary of 2022
Acquisitions - Summary of 2022 Acquisitions (Details) - USD ($) $ in Thousands | Jan. 28, 2022 | Mar. 31, 2022 | Mar. 31, 2021 | Dec. 31, 2021 |
Business Acquisition [Line Items] | ||||
Common stock issued | $ 16,072 | $ 0 | ||
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract] | ||||
Goodwill | $ 1,657,817 | $ 1,620,127 | ||
MindKick, Inc. | ||||
Business Acquisition [Line Items] | ||||
Cash | $ 26,761 | |||
Common stock issued | 16,072 | |||
Fair value of previously held interest | 3,747 | |||
Fair value of total consideration transferred | 46,580 | |||
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract] | ||||
Cash | 2,789 | |||
Intangible assets | 7,450 | |||
Deferred tax liability | (685) | |||
Other assets and liabilities, net | (14) | |||
Total identifiable net assets assumed | 9,540 | |||
Goodwill | 37,040 | |||
Total | $ 46,580 |
Goodwill and Intangible Asset_2
Goodwill and Intangible Assets - Changes in Goodwill (Details) $ in Thousands | 3 Months Ended |
Mar. 31, 2022USD ($) | |
Goodwill [Roll Forward] | |
Balance as of December 31, 2021 | $ 1,620,127 |
Goodwill acquired | 37,040 |
Measurement period adjustments | 650 |
Balance as of March 31, 2022 | $ 1,657,817 |
Goodwill and Intangible Asset_3
Goodwill and Intangible Assets - Schedule of Weighted Average Remaining Life and Carrying Value of Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended |
Mar. 31, 2022 | Dec. 31, 2021 | |
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | $ 898,392 | $ 890,932 |
Accumulated Amortization | (109,248) | (76,546) |
Intangible assets, net | $ 789,144 | $ 814,386 |
Developed technology | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted-Average Useful Life (in Years) | 8 years 9 months 18 days | 8 years 9 months 18 days |
Gross Carrying Amount | $ 586,704 | $ 580,204 |
Accumulated Amortization | (69,565) | (52,811) |
Intangible assets, net | $ 517,139 | $ 527,393 |
Customer relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted-Average Useful Life (in Years) | 2 years 10 months 24 days | 2 years 10 months 24 days |
Gross Carrying Amount | $ 51,121 | $ 50,171 |
Accumulated Amortization | (20,855) | (16,980) |
Intangible assets, net | $ 30,266 | $ 33,191 |
Trademark | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted-Average Useful Life (in Years) | 5 years 8 months 12 days | 5 years 8 months 12 days |
Gross Carrying Amount | $ 60,567 | $ 60,557 |
Accumulated Amortization | (6,634) | (3,937) |
Intangible assets, net | $ 53,933 | $ 56,620 |
Contractual relationship | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted-Average Useful Life (in Years) | 8 years | 8 years |
Gross Carrying Amount | $ 200,000 | $ 200,000 |
Accumulated Amortization | (12,194) | (2,818) |
Intangible assets, net | $ 187,806 | $ 197,182 |
Goodwill and Intangible Asset_4
Goodwill and Intangible Assets - Amortization of Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Amortization expense | $ 32,702 | $ 4,459 |
Goodwill and Intangible Asset_5
Goodwill and Intangible Assets - Expected Amortization of Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Remainder of 2022 | $ 103,715 | |
2023 | 126,386 | |
2024 | 121,868 | |
2025 | 109,928 | |
2026 | 77,256 | |
Thereafter | 249,991 | |
Intangible assets, net | $ 789,144 | $ 814,386 |
Balance Sheet Components - Sche
Balance Sheet Components - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Dec. 31, 2021 | |
Property, Plant and Equipment [Line Items] | |||
Total gross property and equipment | $ 215,219 | $ 203,907 | |
Accumulated depreciation and amortization | (105,049) | (97,801) | |
Property and equipment, net | 110,170 | 106,106 | |
Depreciation and amortization expense | 8,770 | $ 7,373 | |
Leasehold improvements | |||
Property, Plant and Equipment [Line Items] | |||
Total gross property and equipment | 90,661 | 84,006 | |
Computer and other hardware | |||
Property, Plant and Equipment [Line Items] | |||
Total gross property and equipment | 82,878 | 74,953 | |
Furniture | |||
Property, Plant and Equipment [Line Items] | |||
Total gross property and equipment | 28,909 | 27,916 | |
Internally developed software | |||
Property, Plant and Equipment [Line Items] | |||
Total gross property and equipment | 3,508 | 3,508 | |
Purchased software | |||
Property, Plant and Equipment [Line Items] | |||
Total gross property and equipment | 1,013 | 1,449 | |
Construction in progress | |||
Property, Plant and Equipment [Line Items] | |||
Total gross property and equipment | $ 8,250 | $ 12,075 |
Balance Sheet Components - Sc_2
Balance Sheet Components - Schedule of Long Lived Assets by Geographic Region (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Property, Plant and Equipment [Line Items] | ||
Total long-lived assets, net | $ 108,232 | $ 104,111 |
United States | ||
Property, Plant and Equipment [Line Items] | ||
Total long-lived assets, net | 36,937 | 36,718 |
Canada | ||
Property, Plant and Equipment [Line Items] | ||
Total long-lived assets, net | 34,840 | 31,498 |
United Kingdom | ||
Property, Plant and Equipment [Line Items] | ||
Total long-lived assets, net | 14,702 | 15,011 |
Greater China | ||
Property, Plant and Equipment [Line Items] | ||
Total long-lived assets, net | 4,278 | 4,300 |
EMEA, excluding United Kingdom | ||
Property, Plant and Equipment [Line Items] | ||
Total long-lived assets, net | 13,377 | 12,587 |
APAC | ||
Property, Plant and Equipment [Line Items] | ||
Total long-lived assets, net | 2,916 | 3,052 |
Other Americas, excluding Canada | ||
Property, Plant and Equipment [Line Items] | ||
Total long-lived assets, net | $ 1,182 | $ 945 |
Balance Sheet Components - Sc_3
Balance Sheet Components - Schedule of Accrued Expenses and Current Liabilities (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Property, Plant and Equipment [Abstract] | ||
Accrued expenses | $ 63,466 | $ 60,937 |
Accrued compensation | 58,510 | 83,936 |
Accrued expenses and other current liabilities | $ 121,976 | $ 144,873 |
Balance Sheet Components - Narr
Balance Sheet Components - Narrative (Details) - USD ($) | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Property, Plant and Equipment [Line Items] | ||
Capitalized contract cost in period | $ 1,200,000 | $ 2,600,000 |
Capitalized contract cost, amortization period | 3 years | |
Capitalized contract cost, amortization | $ 2,300,000 | 1,000,000 |
Capitalized contract cost, impairment loss | 0 | 0 |
Other Current Assets | ||
Property, Plant and Equipment [Line Items] | ||
Capitalized contract costs | 8,200,000 | 3,800,000 |
Other Assets | ||
Property, Plant and Equipment [Line Items] | ||
Capitalized contract costs | $ 7,300,000 | $ 5,100,000 |
Leases - Narrative (Details)
Leases - Narrative (Details) $ in Millions | 3 Months Ended |
Mar. 31, 2022USD ($) | |
Lessee, Lease, Description [Line Items] | |
Operating lease, weighted average remaining lease term | 5 years 9 months 18 days |
Operating lease, weighted average discount rate, percent | 4.30% |
Lessee, operating lease, lease not yet commenced, undiscounted amount | $ 39.2 |
Minimum | |
Lessee, Lease, Description [Line Items] | |
Operating lease term | 1 year |
Operating lease renewal term | 1 year |
Operating lease termination period | 1 year |
Lessee, operating lease, lease not yet commenced, term | 2 years 1 month 6 days |
Maximum | |
Lessee, Lease, Description [Line Items] | |
Operating lease term | 9 years 9 months 18 days |
Operating lease renewal term | 5 years |
Operating lease termination period | 5 years |
Lessee, operating lease, lease not yet commenced, term | 10 years 8 months 12 days |
Leases - Schedule of Lease Cost
Leases - Schedule of Lease Cost (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Leases [Abstract] | ||
Operating lease expense, excluding ROU asset impairment | $ 7,620 | $ 7,301 |
Short-term lease expense | 270 | 117 |
Variable lease expense | 1,445 | 975 |
Sublease income | 0 | (93) |
Total lease expense | $ 9,335 | $ 8,300 |
Leases - Other Information (Det
Leases - Other Information (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Leases [Abstract] | ||
Cash paid for amounts included in the measurement of operating lease liabilities | $ 5,863 | $ 7,840 |
Operating lease ROU assets obtained in exchange for new operating lease liabilities | $ 9,372 | $ 18,891 |
Leases - Schedule of Future Min
Leases - Schedule of Future Minimum Lease Payments (Details) $ in Thousands | Mar. 31, 2022USD ($) |
Leases [Abstract] | |
Remainder of 2022 | $ 24,118 |
2023 | 27,319 |
2024 | 23,481 |
2025 | 17,828 |
2026 | 11,746 |
Thereafter | 32,331 |
Total future minimum lease payments | 136,823 |
Less: imputed interest | 16,019 |
Present value of lease liabilities | $ 120,804 |
Borrowings - Convertible Notes
Borrowings - Convertible Notes (Details) $ / shares in Units, $ in Millions | 1 Months Ended | 3 Months Ended |
Nov. 30, 2021USD ($)d$ / shares | Mar. 31, 2022USD ($) | |
Debt Instrument [Line Items] | ||
Interest expense related to amortization of debt | $ | $ 1.1 | |
Convertible Debt | 0% Convertible Senior Notes Due 2026 | ||
Debt Instrument [Line Items] | ||
Debt face amount | $ | $ 1,700 | |
Debt interest rate | 0.00% | |
Additional principal amount | $ | $ 225 | |
Proceeds from issuance of notes | $ | $ 1,700 | |
Reporting requirement period | 365 days | |
Special interest requirement | 6 months | |
Special interest period after issuance | 6 months | |
Conversion ratio | 3.2392 | |
Conversion price (in usd per share) | $ / shares | $ 308.72 | |
Convertible Debt | 0% Convertible Senior Notes Due 2026 | On or after November 20, 2024 | ||
Debt Instrument [Line Items] | ||
Conversion price threshold | 130.00% | |
Number of trading days | 20 | |
Number of consecutive trading days | 30 | |
Redemption price percentage | 100.00% | |
Minimum debt outstanding | $ | $ 150 | |
Convertible Debt | 0% Convertible Senior Notes Due 2026 | Immediately preceding August 15, 2026, Circumstance A | ||
Debt Instrument [Line Items] | ||
Conversion price threshold | 130.00% | |
Number of trading days | 20 | |
Number of consecutive trading days | 30 | |
Convertible Debt | 0% Convertible Senior Notes Due 2026 | Immediately preceding August 15, 2026, Circumstance B | ||
Debt Instrument [Line Items] | ||
Number of consecutive trading days | 10 | |
Redemption price percentage | 98.00% | |
Number of business days | 5 | |
Convertible Debt | 0% Convertible Senior Notes Due 2026 | On or after August 15, 2026 | ||
Debt Instrument [Line Items] | ||
Redemption price percentage | 100.00% |
Borrowings - Summary of Convert
Borrowings - Summary of Convertible Note (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Dec. 31, 2021 |
Debt Instrument [Line Items] | ||
Net carrying amount | $ 1,704,145 | $ 1,703,035 |
0% Convertible Senior Notes Due 2026 | ||
Debt Instrument [Line Items] | ||
Principal | 1,725,000 | |
Unamortized debt issuance cost | (20,855) | |
Net carrying amount | $ 1,704,145 |
Borrowings - Capped Call Transa
Borrowings - Capped Call Transaction (Details) - 0% Convertible Senior Notes Due 2026 $ / shares in Units, shares in Millions, $ in Millions | 1 Months Ended |
Nov. 30, 2021USD ($)$ / sharesshares | |
Debt Instrument [Line Items] | |
Net cost incurred | $ | $ 48.1 |
Number of common shares (in shares) | shares | 5.6 |
Strike price (in usd per share) | $ 308.72 |
Cap price (in usd per share) | $ 343.02 |
Commitment and Contingencies -
Commitment and Contingencies - Future Purchase Obligations (Details) $ in Thousands | Mar. 31, 2022USD ($) |
Commitments and Contingencies Disclosure [Abstract] | |
Total | $ 656,988 |
Remainder of 2022 | 81,637 |
2023‑2024 | 279,745 |
2025‑2026 | 295,606 |
Thereafter | $ 0 |
Commitment and Contingencies _2
Commitment and Contingencies - Narrative (Details) - USD ($) $ in Millions | 1 Months Ended | 3 Months Ended | ||
Sep. 30, 2021 | Mar. 31, 2022 | Mar. 31, 2021 | Dec. 31, 2021 | |
Letter of Credit | ||||
Long-term Purchase Commitment [Line Items] | ||||
Letter of credit outstanding | $ 10.7 | $ 10.8 | ||
Cloud Service | ||||
Long-term Purchase Commitment [Line Items] | ||||
Term of commitment | 5 years | 5 years | ||
Minimum commitment amount | $ 700 | |||
Commitment amount spent | $ 32.9 | $ 25.1 |
Stock-Based Compensation - Stoc
Stock-Based Compensation - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Total stock-based compensation expense | $ 103,427 | $ 66,561 |
Cost of revenue | ||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Total stock-based compensation expense | 8,794 | 5,117 |
Research and development | ||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Total stock-based compensation expense | 55,253 | 31,650 |
Sales and marketing | ||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Total stock-based compensation expense | 23,834 | 12,037 |
General and administrative | ||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Total stock-based compensation expense | $ 15,546 | $ 17,757 |
Stock-Based Compensation - Narr
Stock-Based Compensation - Narrative (Details) - USD ($) $ in Thousands | 1 Months Ended | 3 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2022 | Jun. 30, 2021 | Mar. 31, 2021 | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Stock-based compensation expense | $ 103,427 | $ 66,561 | ||
General and administrative | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Stock-based compensation expense | 15,546 | 17,757 | ||
Chief Financial Officer | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Severance benefit payment | $ 300 | |||
Stock-based compensation expense | $ 12,600 | $ 10,500 | ||
Chief Financial Officer | General and administrative | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Severance benefit payment | 300 | |||
Stock-based compensation expense | $ 2,100 |
Stock-Based Compensation - Sche
Stock-Based Compensation - Schedule of Stock Options (Details) - $ / shares | 3 Months Ended | 12 Months Ended |
Mar. 31, 2022 | Dec. 31, 2021 | |
Stock Options Outstanding | ||
Balance as of December 31, 2021 (in shares) | 29,226,041 | |
Granted (in shares) | 1,121,855 | |
Exercised (in shares) | (1,952,058) | |
Forfeited, cancelled, or expired (in shares) | (329,184) | |
Balance as of March 31, 2022 (in shares) | 28,066,654 | 29,226,041 |
Weighted-Average Exercise Price | ||
Balance as of December 31, 2021 (USD per share) | $ 13.28 | |
Granted (USD per share) | 89.01 | |
Exercised (USD per share) | 5.84 | |
Forfeited, cancelled, or expired (USD per share) | 32.16 | |
Balance as of March 31, 2022 (USD per share) | $ 16.60 | $ 13.28 |
Stock Option Activity, Additional Disclosures | ||
Options outstanding, Weighted average remaining contractual term | 6 years 2 months 4 days | 6 years 3 months 3 days |
Stock-Based Compensation - Summ
Stock-Based Compensation - Summary of Valuation Assumptions of Stock Options (Details) - Stock options - $ / shares | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Expected dividend yield | 0.00% | 0.00% |
Risk-free interest rate | 1.70% | 0.90% |
Expected volatility | 33.80% | 36.00% |
Expected term (in years) | 6 years 3 months | 6 years 3 months |
Fair value of underlying common stock (USD per share) | $ 89.01 | |
Minimum | ||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Fair value of underlying common stock (USD per share) | $ 102.80 | |
Maximum | ||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Fair value of underlying common stock (USD per share) | $ 108.10 |
Stock-Based Compensation - Su_2
Stock-Based Compensation - Summary of Restricted Stock Unit Activity (Details) - Unvested RSUs | 3 Months Ended |
Mar. 31, 2022$ / sharesshares | |
Unvested Restricted Stock Units | |
Unvested as of December 31, 2021 (in shares) | shares | 13,696,836 |
Granted (in shares) | shares | 3,332,753 |
Vested (in shares) | shares | (957,467) |
Forfeited (in shares) | shares | (443,328) |
Unvested as of March 31, 2022 (in shares) | shares | 15,628,794 |
Weighted-Average Grant-Date Fair Value | |
Unvested as of December 31, 2021 (USD per share) | $ / shares | $ 85.96 |
Granted (USD per share) | $ / shares | 89.09 |
Vested (USD per share) | $ / shares | 87.13 |
Forfeited (USD per share) | $ / shares | 79.94 |
Unvested as of March 31, 2022 (USD per share) | $ / shares | $ 86.73 |
Stock-Based Compensation - Su_3
Stock-Based Compensation - Summary of Valuation Assumptions of Employee Stock Purchase Plans (Details) - Employee Stock | 3 Months Ended |
Mar. 31, 2022$ / shares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Expected dividend yield | 0.00% |
Risk-free interest rate | 0.60% |
Expected volatility | 40.00% |
Expected term (in years) | 6 months |
Estimated fair value (USD per share) | $ 27.42 |
Stock-Based Compensation - Su_4
Stock-Based Compensation - Summary of ESPP (Details) - Employee Stock | 3 Months Ended |
Mar. 31, 2022$ / sharesshares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Shares issued under the ESPP (in shares) | shares | 2,079.86 |
Weighted-average price per share issued (in usd per share) | $ / shares | $ 90.48 |
Income Taxes - Narrative (Detai
Income Taxes - Narrative (Details) $ in Millions | Mar. 31, 2022USD ($) |
Income Tax Disclosure [Abstract] | |
Unrecognized tax benefits | $ 121.8 |
Unrecognized tax benefits that would impact effective tax rate | 11.4 |
Decrease in unrecognized tax benefits is reasonably possible | $ 1.8 |
Net Loss per Share of Common _3
Net Loss per Share of Common Stock - Schedule of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Numerator: | ||
Net loss attributable to our common stockholders, basic | $ (177,555) | $ (107,460) |
Net loss attributable to our common stockholders, diluted | $ (177,555) | $ (107,460) |
Denominator: | ||
Weighted-average common shares used in per share computation, basic (in shares) | 294,341 | 276,068 |
Weighted-average common shares used in per share computation, diluted (in shares) | 294,341 | 276,068 |
Net loss per share, basic (USD per share) | $ (0.60) | $ (0.39) |
Net loss per share, diluted (USD per share) | $ (0.60) | $ (0.39) |
Net Loss per Share of Common _4
Net Loss per Share of Common Stock - Antidilutive Securities Excluded From Computation (Details) - shares shares in Thousands | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Convertible notes | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive securities excluded from computation of earnings per share (in shares) | 12,441 | 0 |
Stock options | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive securities excluded from computation of earnings per share (in shares) | 28,067 | 36,838 |
Unvested RSUs | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive securities excluded from computation of earnings per share (in shares) | 15,629 | 11,263 |